Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angioedemas, Hereditary”

190 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 190 results

Not applicableStudy completedNCT03845400
What this trial is testing

Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America

Who this might be right for
Hereditary Angioedema (HAE)
Shire 168
Not applicableStudy completedNCT03558009
What this trial is testing

Epidemiological Analysis for Hereditary Angioedema Disease

Who this might be right for
Abdominal PainFunctional Abdominal Pain
CENTOGENE GmbH Rostock 2,318
Large-scale testing (Phase 3)Study completedNCT05511922
What this trial is testing

PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120830
What this trial is testing

NTLA-2002 in Adults With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
Intellia Therapeutics 37
Large-scale testing (Phase 3)Ended earlyNCT01275976
What this trial is testing

Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture

Who this might be right for
TraumaInflammationSepsis+1 more
UMC Utrecht 11
Not applicableStudy completedNCT01059526
What this trial is testing

Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 81
Very early researchEnded earlyNCT01694381
What this trial is testing

Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor

Who this might be right for
Acute Ischemic Stroke
TSI, LLC 8
Testing effectiveness (Phase 2)Study completedNCT01756157
What this trial is testing

Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks

Who this might be right for
Hereditary Angioedema (HAE)
Shire 47
Not applicableStudy completedNCT04130191
What this trial is testing

Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

Who this might be right for
Hereditary Angioedema (HAE)
Shire 140
Early research (Phase 1)Study completedNCT02093923
What this trial is testing

A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants

Who this might be right for
Hereditary Angioedema (HAE)
Shire 38
Testing effectiveness (Phase 2)Study completedNCT04618211
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 74
Large-scale testing (Phase 3)Active Not RecruitingNCT06634420
What this trial is testing

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
Intellia Therapeutics 80
Not applicableStudy completedNCT01541423
What this trial is testing

A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 83
Early research (Phase 1)Study completedNCT02663687
What this trial is testing

Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects

Who this might be right for
Hereditary Angioedema (HAE)
Shire 48
Large-scale testing (Phase 3)Enrolling By InvitationNCT06679881
What this trial is testing

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Who this might be right for
Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V. 170
Early research (Phase 1)Study completedNCT02125162
What this trial is testing

The Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161

Who this might be right for
Hereditary Angioedema
BioCryst Pharmaceuticals 28
Large-scale testing (Phase 3)WithdrawnNCT01253382
What this trial is testing

Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire
Not applicableStudy completedNCT01034969
What this trial is testing

Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 1,761
Not applicableStudy completedNCT05578417
What this trial is testing

Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in Canada

Who this might be right for
Hereditary Angioedema (HAE)Angioedema
Takeda 60
Not applicableApproved For MarketingNCT03177005
What this trial is testing

Expanded Access for Hereditary Angioedema (HAE)

Joshua S. Jacobs, MD
Next Page